SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 71.41 |
| Enterprise Value ($M) | 32.39 |
| Book Value ($M) | 71.64 |
| Book Value / Share | 1.53 |
| Price / Book | 1.00 |
| NCAV ($M) | 54.53 |
| NCAV / Share | 1.17 |
| Price / NCAV | 1.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.00 |
| Return on Assets (ROA) | -0.67 |
| Return on Equity (ROE) | -0.81 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.95 |
| Current Ratio | 2.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 100.58 |
| Assets | 117.69 |
| Liabilities | 46.06 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -89.68 |
| Net Income | -84.26 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -51.22 |
| Cash from Investing | 8.76 |
| Cash from Financing | 29.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Invus Global Management, LLC | 4.90 | 0.00 | |
| 13G/A | Deep Track Capital, LP | 3.92 | -57.42 | |
| 13G/A | Citadel Advisors Llc | 3.60 | ||
| 13D/A | Vida Ventures GP III, L.L.C. | 12.70 | 0.52 | |
| 13G/A | Artal International S.C.A. | 4.90 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 25,413 | 88,841 | 28.61 | |
| 94,971 | 252,555 | 37.60 | |
| 27,969 | 71,015 | 39.38 | |
| 46,557 | 176,526 | 26.37 | |
| 23,042 | 92,803 | 24.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UBX – Unity Biotechnology, Inc. | UTHR – United Therapeutics Corporation |
| VERV – Verve Therapeutics, Inc. | VIR – Vir Biotechnology, Inc. |
| VOR – Vor Biopharma Inc. |
Financial data and stock pages provided by
Fintel.io